bpc 157 clinical evidence randomized trial humans Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review Christopher Mendias, PhD, gets four

I had Pfizer vaccine on 2/1 at 2:30

Whats BPC 157

AOD9604 stimulates lipolysis and inhibits lipogenesis without inducing IGF-1, making it a safer alternative for fat loss without growth promotion. Ng et al., Obesity Research & Clinical Practice Initially developed by Metabolic Pharmaceuticals in Australia, AOD9604 was studied for obesity treatment and has since been embraced by anti-aging clinics and performance-focused users for localized fat reduction, metabolic support, and recovery assistance especially in people who want to avoid the risks of hGH or stimulants

Around the same time, the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study reported that 47% of adolescents who underwent such surgeries screened positive for potential hazardous drinking or AUD symptoms eight years later (309)

Similarly, its not meant for large-volume IV infusion